Ann: First shipments and regulatory submissions for COVID-19 test, page-22

What’s not to like about this announcement.

”CE-IVD marking and inclusion on the ARTG creates a significant opportunity for Genetic Signatures as laboratories and governments seek fast and accurate tests” - Reading a lot of misinformation about 15minute tests that have come out of nowhere in recent weeks. I probably like many bought into GSS way before any thought of covid-19 came along, and their testing technology far more proven than some 5 minute wonders. Really good opportunity to gain some traction in this space and by the sound of this announcement, the test kit at a standard better than most.


Irrespective of coronavirus - As per announcement, “The Company has introduced laboratories in Europe and Australia to both the new test and its 3baseTM technology” Massive potential upside. Must say I expected a larger percentage rise today yet as in for the long haul, huge opportunity for GSS to show their wares. $1.36 a steal considering this was mid $1.20s on the Last quarterly report when Covid 19 was merely mentioned, and now with a big foot in the door, and only 10% higher since then, no brainer for me.